Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitro.
about
Pleiotropic effects of statins in the diseases of the liverAssociation between hepatitis B and metabolic syndrome: Current state of the artHepatitis B virus therapy: What's the future holding for us?Review article: prescribing medications in patients with cirrhosis - a practical guide.Screening and identification of compounds with antiviral activity against hepatitis B virus using a safe compound library and novel real-time immune-absorbance PCR-based high throughput system.2-amino-N-(2,6-dichloropyridin-3-yl)acetamide derivatives as a novel class of HBV capsid assembly inhibitor.Quantitative NTCP pharmacophore and lack of association between DILI and NTCP Inhibition.Statin-Based Palliative Therapy for Hepatocellular CarcinomaEffect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c miceMeta-analysis of studies using statins as a reducer for primary liver cancer risk.Do statins reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis B?Clinical perspective: statins and the liver--harmful or helpful?Antihepatitis B therapy: a review of current medications and novel small molecule inhibitors.Antiviral drug discovery: broad-spectrum drugs from nature.Systematic review of the in vitro effects of statins on oral and perioral microorganisms.Sodium selenite suppresses hepatitis B virus transcription and replication in human hepatoma cell lines.Inhibition of hepatitis B virus replication by quercetin in human hepatoma cell lines.Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus.Current landscape and future prospects of antiviral drugs derived from microbial products.Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells.
P2860
Q26741176-B33C5BD2-F4E9-4B82-A2BF-055F762593B6Q26772343-F19794CE-D13F-40E5-A658-18C9C9A80620Q26774198-1E22DAEA-0F65-4626-8C0F-0560D667531EQ34342554-30F85B19-50F6-4A9C-81DC-091EB6989557Q34588956-2E0DE86D-92E5-4C10-85F1-A8DB3A0601C3Q35076698-9EAF53F4-02D9-4423-9190-D785C126BFC7Q35185827-F457DD10-9108-4309-BBD9-2FDE4D6EBE20Q36206887-49CBEADF-9A71-44DD-9F9D-37A2B611B16EQ36607954-5805D59F-B656-444E-9953-75C23C30F581Q36919251-AD4995D9-6A1F-4FFF-9FA7-9BA84680D108Q37584603-25F6BEF7-D0AC-45F0-9D6E-100638729911Q38009719-523C2055-8E11-4713-BD3C-24200C646BA1Q38151881-EE590933-010E-4984-A768-D9DBEB3944F1Q38260235-9632CA97-45FB-4A28-875A-757193EA81EDQ38683382-8491B3DE-9306-428F-B4D8-428DFC997AF5Q38838683-F8425F10-4BDB-421C-AF5C-A28EA0437C5BQ38844134-08C7CC77-BD5A-4EC0-85CF-7B3E4C826621Q40260177-E4AD3F2B-FB5B-4107-B2F5-4D8A7097F549Q41919714-E5422879-5C62-44FE-945A-507EB24D152BQ42242795-FF0EB01A-93C3-4ED5-B268-8F0511E9C80B
P2860
Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitro.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Simvastatin potentiates the an ...... analogue inhibitors in vitro.
@ast
Simvastatin potentiates the an ...... analogue inhibitors in vitro.
@en
type
label
Simvastatin potentiates the an ...... analogue inhibitors in vitro.
@ast
Simvastatin potentiates the an ...... analogue inhibitors in vitro.
@en
prefLabel
Simvastatin potentiates the an ...... analogue inhibitors in vitro.
@ast
Simvastatin potentiates the an ...... analogue inhibitors in vitro.
@en
P2860
P1433
P1476
Simvastatin potentiates the an ...... analogue inhibitors in vitro.
@en
P2093
Brent Korba
P2860
P304
P356
10.1016/J.ANTIVIRAL.2010.02.325
P577
2010-03-06T00:00:00Z